USSTOCK.TODAY
Regular Market
Log in Sign up

ImmunityBio, Inc. Reports $184.6 Million Loss in Third Quarter

Associated Press · ·by G4L

IBRX
IBRX ImmunityBio Inc
$8.64 +7.80%
View chart & analysis →
  1. 1ImmunityBio, Inc. recorded a loss of $184.6 million in the third quarter.
  2. 2ImmunityBio, Inc. reported a loss of 18 cents per share in the third quarter.
  3. 3ImmunityBio, Inc. revenue was $48.8 million in the third quarter.

So what's the key point?

ImmunityBio, Inc. saw a loss of $184.6 million in the third quarter. This means the company spent much more money than it earned.

Source Associated Press · View original ↗

Related 3-line summaries

Goldman discloses combined ~$75M stake in CAPR, SLS, and IBRX Stocktwits +1 · Aug 17UAE grants ImmunityBio's Anktiva broad approval for bladder and lung cancer Stocktwits +8 · Jul 30PayPal Leaves Door Open to Higher Acquisition Bid Amid Strong Earnings Stocktwits +5 · Jul 29
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news